Fermenta Biotech LimitedFERMENTACorporate

Pharmaceuticals Latest results: Jun 2026 6 quarters of data

₹486.00

MCap ₹1,393 Cr · P/E 21.9

Fermenta Biotech Limited — Stock analysis & AI research Fermenta Biotech Limited — Multibagger AI analysis Fermenta Biotech Limited — Seasonality — best & worst months Fermenta Biotech Limited — Technical setup — score, trend, support & resistance Fermenta Biotech Limited — Live exchange announcements

📈 MACD Bearish Crossover 📈 Accumulation (OBV Rising) 🏭 Pharma sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹112 Cr

Sales · Jun 2026

-17.9% YoY

₹23 Cr

Operating Profit · Jun 2026

-18.6% YoY

20.5%

OPM % · Jun 2026

-1.0% YoY

₹15 Cr

Net Profit · Jun 2026

-30.6% YoY

₹5.23

EPS · Jun 2026

-29.5% YoY

📝 Fermenta Biotech Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Fermenta Biotech Limited reported revenue of ₹112 crore for the quarter ended June 2026 (Q1 FY27), down 17.9% from ₹136 crore in the same quarter last year, and down 8.0% sequentially over the March 2026 quarter.

Net profit fell 30.6% year-on-year to ₹15 crore, from ₹22 crore. Earnings per share (EPS) came in at ₹5.23.

Operating profit stood at ₹23 crore — an operating margin (OPM) of 20.5%, compared with 20.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Fermenta Biotech Limited posted revenue of ₹525 crore, with a net profit of ₹70 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹501 crore with a net profit of ₹64 crore.

Valuation snapshot

At the current price of ₹486.00, FERMENTA has a market capitalisation of ₹1,393 crore and a trailing P/E of about 21.9.

Within the Pharmaceuticals industry, it is the 6th-largest of the 82 companies we track by market value.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹1,393 Cr

Current Price ?

₹486.0

P/E ?

21.90below ind

Industry P/E ?

22.40

P/B ?

N/A

P/S ?

2.78

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

4.6%

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

₹501 Cr

OPM ?

18.9%

Profit after tax (TTM) ?

₹64 Cr

EPS (TTM) ?

₹22.20

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹112 Cr

PAT — latest qtr ?

₹15 Cr

YoY qtr sales growth ?

-17.9%

YoY qtr profit growth ?

-30.6%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

6.8

Current Ratio ?

N/A

Ownership

Promoter holding ?

N/A

Change in promoter holding ?

N/A

Pledged percentage ?

N/A

Market

Return 3 months ?

12.3%

Return 6 months ?

52.6%

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	140	136	130	137	122	112	-17.9%	-8.0%
Operating Profit	37	28	27	25	20	23	-18.6%	+14.9%
Other Income	4	9	5	1	14	5	-44.2%	-65.4%
Interest	3	3	3	3	3	3	-18.4%	-10.0%
Depreciation	6	6	5	5	5	5	-10.7%	+1.5%
Profit Before Tax	32	28	24	17	26	20	-28.3%	-23.1%
Net Profit	33	22	18	12	19	15	-30.6%	-19.4%
EPS	11.68	7.42	6.14	4.31	6.52	5.23	-29.5%	-19.8%
OPM %	26.4%	20.7%	20.5%	18.2%	16.5%	20.5%	-1.0%	+24.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY26	TTM	YoY %
Sales	—	₹525 Cr	₹501 Cr	—
Operating Profit	—	₹100 Cr	₹95 Cr	—
OPM %	—	19.00%	18.88%	—
NPM %	—	13.37%	12.70%	—
Other Income	—	₹29 Cr	₹25 Cr	—
Depreciation	—	₹22 Cr	₹21 Cr	—
Interest	—	₹12 Cr	₹11 Cr	—
EBIT	—	₹78 Cr	₹73 Cr	—
PBT	—	₹96 Cr	₹88 Cr	—
Tax	—	—	₹5 Cr	—
Net Profit	—	₹70 Cr	₹64 Cr	—
EPS	—	₹24.39	₹22.20	—
Material Cost	—	—	₹46 Cr	—
Employee Cost	—	—	₹20 Cr	—
Extraordinary Items	—	—	—	—

⚖️ Peer comparison

Industry: Pharmaceuticals · top 25 of 82 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	SUDEEPPHRM Sudeep Pharma	₹1,033.30	11,671	63.3	675	184	34.6%	27.3%	—	—	26.6%	30.9%
2	SPARC Sun Pharma	₹185.08	6,006	3.8	1,909	1,584	84.7%	83.0%	2512.3%	553.9%	314.1%	59.9%
3	GUJTHEM Gujarat Themis	₹412.60	5,370	92.3	173	48	47.3%	27.8%	8.6%	-6.1%	21.6%	23.0%
4	539997 Kwality Pharmaceuticals	₹2,652.10	3,525	34.0	553	81	24.4%	14.6%	35.7%	71.8%	46.3%	113.5%
5	524632 Shukra Pharmaceuticals	₹80.95	2,403	99.9	75	36	65.0%	48.2%	74.0%	130.1%	336.4%	1359.2%
6	FERMENTA Fermenta Biotech	₹475.00	1,362	21.4	501	64	18.9%	12.7%	—	—	-17.9%	-30.6%
7	506414 Fermenta Biotech	₹552.60	1,313	27.2	511	59	17.6%	11.5%	11.9%	-6.6%	-10.4%	-56.7%
8	AHCL Anlon Healthcare	₹20.20	1,074	—	—	—	—	—	—	—	163.0%	133.3%
9	541096 Bharat Parenterals	₹1,525.00	1,062	—	323	-30	3.3%	-9.3%	1.5%	37.5%	-19.2%	-309.6%
10	540737 Shree Ganesh	₹796.30	855	66.2	99	15	31.4%	15.6%	0.7%	-23.0%	-41.8%	-67.5%
11	AMANTA Amanta Healthcare	₹197.75	768	52.5	291	15	20.4%	5.0%	—	—	5.4%	-5.6%
12	539730 Fredun Pharmaceuticals	₹827.85	611	10.3	747	44	14.7%	5.9%	40.1%	90.0%	90.2%	88.1%
13	500422 Transchem Ltd-$	₹38.00	474	10.8	—	4	—	—	-100.0%	-17.8%	-100.0%	186.3%
14	HALEOSLABS Haleos Labs	₹1,525.00	461	21.0	324	15	12.6%	4.7%	-3.2%	-4.9%	-11.6%	-58.0%
15	524731 Jenburkt Pharmaceuticals	₹865.75	404	11.6	170	33	23.6%	19.4%	11.8%	6.1%	-1.4%	-26.4%
16	543616 Trident Lifeline	₹279.85	364	14.0	134	24	24.6%	17.9%	—	—	42.6%	44.2%
17	512600 Astal Laboratories	₹75.00	308	32.3	170	10	8.8%	5.7%	142.9%	-9.0%	56.0%	77.4%
18	524828 BDH Industries	₹336.80	300	16.6	100	12	15.3%	11.7%	44.3%	16.6%	20.2%	48.8%
19	500009 Ambalal Sarabhai	₹38.73	297	21.9	206	14	7.1%	6.6%	3.1%	261.1%	8.0%	-51.6%
20	532039 Zenotech Laboratories	₹64.90	263	—	45	-3	17.0%	-5.6%	1.3%	-119.2%	10.1%	-146.0%
21	531739 Gennex Laboratories	₹13.87	255	19.0	183	21	14.4%	11.3%	24.9%	15.5%	16.6%	-6.9%
22	524790 Everest Organics	₹159.20	252	29.4	191	5	10.3%	2.8%	23.0%	527.7%	-10.0%	-21.1%
23	530163 Kerala Ayurveda	₹310.20	225	—	125	-26	-14.9%	-20.8%	9.0%	-16.8%	-21.3%	-477.8%
24	531569 Sanjivani Paranteral	₹199.95	214	32.7	66	7	15.3%	11.3%	-7.6%	-14.4%	8.8%	32.7%
25	524636 Oxygenta Pharmaceutical	₹32.25	195	—	135	-14	-5.9%	-10.1%	3.3%	-70.8%	144.5%	65.6%

❓ Frequently asked questions

What was Fermenta Biotech Limited's revenue in Q1 FY27?

What was Fermenta Biotech Limited's net profit in Q1 FY27?